Oncogenic PIK3CA mutations in colorectal cancers and polyps.
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseImpact of somatic mutations on patterns of metastasis in colorectal cancerTreatment Individualization in Colorectal CancerMolecular phenotypes of colorectal cancer and potential clinical applicationsDiscovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyWhat influences preneoplastic colorectal lesion recurrence?Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survivalPIK3CA gene mutations in Northwest Chinese esophageal squamous cell carcinomaPI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases.Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.Microsatellite stable colorectal cancers stratified by the BRAF V600E mutation show distinct patterns of chromosomal instability.DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2.FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasionPIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal CancerRAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancerHow many diseases are colorectal cancer?Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathwaySomatic mutation in PIK3CA is a late event in cervical carcinogenesis.PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival.Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study.Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.Descriptive profile of PIK3CA-mutated colorectal cancer in postmenopausal women.Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.PIK3CA and APC mutations are synergistic in the development of intestinal cancers.Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.Gene of the month: PIK3CA.PIK3CA gene mutations and amplifications in Chinese patients with ovarian clear cell carcinoma.Pyrosequencing evaluation of low-frequency KRAS mutant alleles for EGF receptor therapy selection in metastatic colorectal carcinoma.Serrated tubulovillous adenoma of the large intestine.PIK3CA mutation and methylation influences the outcome of colorectal cancerOncogenic PIK3CA mutations in lobular breast cancer progression.Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer.Genome-wide DNA methylation analysis of formalin-fixed paraffin embedded colorectal cancer tissue.MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.Oncogenic mutations in extramammary Paget's disease and their clinical relevance.Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231).Copy number profiles of paired primary and metastatic colorectal cancers.
P2860
Q24289344-C5E54178-69EC-48BE-A5E9-63E30E10F7CCQ26772279-C1AFC8EE-1D58-4862-AB7E-897516327A1DQ26776215-119C6786-A70A-4C12-94CA-42D922C429B0Q26785725-A8305E6B-8C30-481F-BB43-FF3FDF648C0DQ27011884-025E5134-0379-422E-A322-B31629A6B3E7Q28072915-6771F8A2-F55F-4F39-8390-6AA88FD31DF1Q28277824-1C721DAF-AB44-474B-8F52-B0C55AD592E4Q33572680-02A23FD1-3C4D-49D2-8DE0-57FF3D23A3B0Q33618754-2420A2AC-9D34-4241-9359-248B444C683EQ33732199-733793BE-56D3-4496-9AEE-0E64189D2AEFQ34008641-42DACA81-6BDB-4189-B361-B44D4D400E5AQ34778710-27DFBE43-423B-493B-BD6B-BFC7849D3057Q35052681-4BD385E4-07DD-49C5-BCD2-2C9D245A11B1Q35126713-75BD5C65-EB3E-46F1-ACD2-70A7E96EDB13Q35740115-46E45C95-B295-4B6D-93B0-967AE3D50446Q35743041-E0CA4417-426C-4A4C-9788-FEF9A97695DFQ35815544-78AC9337-7977-472B-A311-78D3D3F32ADBQ35911017-64FB8000-0D2E-468D-A15A-0DB28FE5A143Q36238965-CFB569F4-33FF-44D7-858C-63B003C5D68BQ37046419-5911C279-DE09-4B42-B711-7A59FC579200Q37082560-66AEACD2-1729-41DA-A652-83F832525D42Q37236257-13BF81FC-35A7-4889-ABD3-E1598E0ECC61Q37241845-7DE5C908-BF9E-4506-9495-A768C48783F3Q37274510-638B35B7-56FA-4A9F-BC17-EA5D6B4D1582Q37315483-BC831BA7-C5F8-47C6-9053-96BB599A6344Q37360360-8756FE8F-A878-492C-B691-C30DB74E2682Q37445892-4AC32165-47AD-44C6-8EED-D73BF1520DD8Q38272701-D8AEADD0-3AA3-4F6B-B489-CE71B7D6AF81Q38358055-672B8B66-F971-45C5-84D5-F3DBC65AE338Q39050475-FA045370-D2D1-464B-9D25-7E8A2C8BF29BQ39198062-8E87584A-707E-4BD3-B798-490ACE037792Q41545966-B7457F0A-8A13-41C2-A690-66EB2C93A6BAQ41850443-75898B60-78E6-4ACA-A1C0-BE07AEFD548FQ42513022-4AAB329F-892F-40C5-A42C-9CBB2F8CCB25Q42700799-A9966899-9D67-44DF-A828-7CCD964921D8Q44497822-78198F39-925B-4323-9978-16EA0EE55CC8Q44981365-5A288D26-CBC1-45AD-851B-8A1586D04043Q46574069-7800EFDE-40F2-4D46-A773-640DF09CE518Q48152048-FEE3A966-899F-49AE-A844-4AB51F1DBC49Q50105696-64004CFE-1CE6-47DA-A3F5-FB43E983A51D
P2860
Oncogenic PIK3CA mutations in colorectal cancers and polyps.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Oncogenic PIK3CA mutations in colorectal cancers and polyps.
@en
Oncogenic PIK3CA mutations in colorectal cancers and polyps.
@nl
type
label
Oncogenic PIK3CA mutations in colorectal cancers and polyps.
@en
Oncogenic PIK3CA mutations in colorectal cancers and polyps.
@nl
prefLabel
Oncogenic PIK3CA mutations in colorectal cancers and polyps.
@en
Oncogenic PIK3CA mutations in colorectal cancers and polyps.
@nl
P2093
P2860
P356
P1476
Oncogenic PIK3CA mutations in colorectal cancers and polyps.
@en
P2093
Aarti Umapathy
Barbara A Leggett
Catherine E Bond
Celestine Rickman
Daniel L Worthley
Diane McKeone
Ingunn Ramsnes
Jeremy R Jass
Kenji Notohara
Nagahide Matsubara
P2860
P304
P356
10.1002/IJC.26440
P577
2011-11-19T00:00:00Z